Genetic association analysis of the adiponectin polymorphisms in type 2 diabetes with and without complications

Iranian Journal of Diabetes and Lipid Disorders

Volumn 10, Issue , 2011, Pages 1-4

  Ranjbar, Shirin Hasani ^a   Amoli, Mahsa M ^a   Sajadi, Mohammadali ^b   Balaei, Parisa ^b   Amiri, Parvin ^a   Namakchian, Mahsa ^a   Heshmet, Ramin ^a   Mirzaee, Mohammadreza ^b   Rezazadeh, Ebrahim ^b   Bazzaz, Javad Tavakkoly ^c   Larijani, Bagher ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiponectin; Complications; Diabetes; Polymorphism

Indexed keywords

ADIPONECTIN;

ADULT; ALLELE; ARTICLE; BASE PAIRING; BODY MASS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DNA DETERMINATION; ETHNICITY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 81755188360     PISSN: 17267544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007; 56(5):1198-209.
2. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Movoi M, Matsui J, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol chem 2002; 277: 25863-25866.
3. Hotta K, Funahashi T, Arita Y, Takahash M, Matsuda M, Okamoto Y, Lwahashi H. Plasma concentrations of a novel adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterio sclero Thromb vasc biology. 2000; 20: 1595-1599.
4. Vasseur F. Helbecque N. Lobbens S. Vasseur-Delannoy V. Dina C. Clement K. et al. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectinencoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia 2005; 48(5):892-9.
5. DCCT Research group. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes. 1988; 37(4):476-81.
6. Schaffler A, Buchler C, Muller-Ladner U, Herfarth H, Ehling A, Paul G, et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res. 2004; 36(10):702-7.
7. Ma J, Mollsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF. Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy. J Diabetes Complication. 2007; 21(1):28-33.
8. Rudofsky G, Schlimme M, Schlotterer A, von Eynatten M, Reismann P, Tafel J, et al. No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications. Diabetes Obes Metab. 2005; 7(4):455-9.
9. Buzzetti R, Petrone A, Zavarella S, Zampetti S, Spoletini M, Potenziani S, et al. The glucose clamp reveals an association between adiponectin gene polymorphisms and insulin sensitivity in obese subjects. Int J Obes 2007; 31(3):424-8.
10. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11(21):2607-14.